Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
Authors
Keywords
Silent hypoxemia, High-altitude hypoxia, Hypoxic acclimatization, Acute respiratory distress, Respiratory system
Journal
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
Volume 279, Issue -, Pages 103476
Publisher
Elsevier BV
Online
2020-06-06
DOI
10.1016/j.resp.2020.103476

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.